UBS AM’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Buy |
|
|||||
|
2025
Q1 | $11.4M | Buy |
|
|||||
|
2024
Q4 | $18.6M | Sell |
|
|||||
|
2024
Q3 | $29.9M | Sell |
|
|||||
|
2024
Q2 | $25.4M | Buy |
|
|||||
|
2024
Q1 | $29.2M | Sell |
|
|||||
|
2023
Q4 | $8.84M | Sell |
|
|||||
|
2023
Q3 | $5.3M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $333K | Hold |
|
|||||
|
2021
Q4 | $511K | Hold |
|
|||||
|
2021
Q3 | $698K | Sell |
|
|||||
|
2021
Q2 | $774K | Buy |
|
|||||
|
2021
Q1 | $634K | Sell |
|
|||||
|
2020
Q4 | $724K | Buy |
|
|||||
|
2020
Q3 | $420K | Hold |
|
|||||
|
2020
Q2 | $520K | Sell |
|
|||||
|
2020
Q1 | $406K | Sell |
|
|||||
|
2019
Q4 | $702K | Buy |
|
|||||
|
2019
Q3 | $559K | Buy |
|
|||||
|
2019
Q2 | $545K | Buy |
|
|||||
|
2019
Q1 | $470K | Buy |
|
|||||
|
2018
Q4 | $205K | Buy |
|